The conference “Diagnostic Histopathology of Bone and Soft Tissue Tumors. An update based on WHO Classification” will gather experts and participants from all over the world and it will be held in Padua May, 05th - 06th 2022.

The Department of Pathology of Azienda Ospedale-Università Padova, organizes a two-day course focused upon the diagnostic pathology and molecular genetics of bone and soft tissue tumors. Tumors are difficult to diagnostic. Accuracy of the diagnosis is therefore essential on the treatment and, in substance, on the result. For this reason, there is an extreme need for diagnostic competence.

The course will be co-directed by Prof. Christopher D. M Fletcher, Professor of Pathology, Harvard Medical School, Boston, MA, USA and by Prof. Angelo Paolo Dei Tos, Professor of Pathology, University of Padua School of Medicine, Italy. The course will include lectures and slide seminars. 

Video invitation from Professor Angelo Paolo Dei Tos 

Slides submission

Attendees are invited to submit cases for the Diagnostic Histopathology Slide Seminar by April, 20th 2022.

For each case, submission of a short clinical history, and a paraffin block form which at least 70 sections can be prepared, is required.

The most relevant cases will be evaluated by the Scientific Board and presented during the dedicated sessions. For any further information please contact the organizing secretariat.

Registration fee 

For complete course for attendees is:

- Delegates - NON S.I.A.P.E.C. Members | 488,00 €
- Delegates - S.I.A.P.E.C. Members and biologist | 427,00 €
- Trainees and fellows | 122,00 €

Italian VAT 22% is included. Registration is confirmed only once payment has been verified. 

Please note: in order to register, you should first create your personal account (if you don't already have one) and then proceed with the meeting registration.

The official language of the meeting is English.

An Italian accreditation at Age.na.s has been made with 13 Italian CME credits. Italian CME ID is 343673.

UEMS-EACCME® accreditation (for foreigner attendees).

The Diagnostic Histopathology of Bone and Soft Tissue Tumors. An update based on WHO Classification, Padua, Italy, 05/05/2022-06/05/2022 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 12 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

Covid 19 info 

As of 1 February 2022, the validity of COVID-19 Green Pass to access activities and services in Italy is 6 months.

Those who come from a foreign country and are in possession of a certificate of recovery from Covid-19 or vaccination with a vaccine authorised or recognised as equivalent in Italy, issued by the competent foreign health authorities, where six to nine months have elapsed since the completion of the vaccination cycle or recovery, are allowed access to services and activities for which the Green Pass is provided after having carried out a rapid antigen test swab (valid for 48 hours) or molecular test swab (valid for 72 hours).

In the case of vaccinations with vaccines that are not authorised or not recognised as equivalent in Italy, access to services and activities is allowed in any case after having carried out a rapid antigen test swab (valid for 48 hours) or molecular test swab (valid for 72 hours) with a negative result for the SARS-CoV-2 virus.

Access to meeting venue is allowed only with FFP2 mask always correctly worn.

Tags